KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Amortization - Intangibles (2016 - 2025)

Jazz Pharmaceuticals has reported Amortization - Intangibles over the past 16 years, most recently at $169.7 million for Q4 2025.

  • Quarterly results put Amortization - Intangibles at $169.7 million for Q4 2025, up 6.82% from a year ago — trailing twelve months through Dec 2025 was $659.1 million (up 5.07% YoY), and the annual figure for FY2025 was $654.7 million, up 4.36%.
  • Amortization - Intangibles for Q4 2025 was $169.7 million at Jazz Pharmaceuticals, up from $168.4 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for JAZZ hit a ceiling of $172.1 million in Q1 2022 and a floor of $68.2 million in Q1 2021.
  • Median Amortization - Intangibles over the past 5 years was $155.2 million (2024), compared with a mean of $150.6 million.
  • Biggest five-year swings in Amortization - Intangibles: skyrocketed 152.37% in 2022 and later decreased 12.96% in 2023.
  • Jazz Pharmaceuticals' Amortization - Intangibles stood at $157.3 million in 2021, then decreased by 12.66% to $137.4 million in 2022, then grew by 10.31% to $151.6 million in 2023, then increased by 4.85% to $158.9 million in 2024, then rose by 6.82% to $169.7 million in 2025.
  • The last three reported values for Amortization - Intangibles were $169.7 million (Q4 2025), $168.4 million (Q3 2025), and $162.1 million (Q2 2025) per Business Quant data.